Injectafer (Ferric Carboxymaltose) – 750 mg/15 mL

Injectafer is an intravenous iron replacement therapy (ferric carboxymaltose) used to treat iron deficiency. Each 15 mL vial contains 750 mg elemental iron (50 mg/mL). Ferric carboxymaltose is a large, polynuclear iron(III)-carbohydrate complex; it is a stable, non-dextran formulation that delivers iron to the body without releasing large amounts of free iron.

Indications

Injectafer is indicated for iron deficiency in the following situations (per U.S. prescribing information):

• Iron Deficiency Anemia (IDA): Adults and pediatric patients ≥1 year old who are intolerant of, or have an unsatisfactory response to, oral iron).
• Chronic Kidney Disease (non-dialysis): Adult patients with IDA and non-dialysis-dependent chronic kidney disease.
• Heart Failure: Adult patients with iron deficiency (with or without anemia) and NYHA class II/III heart failure, to improve exercise capacity.

Dosage and Administration

Injectafer is administered intravenously by slow infusion or injection only. Recommended dosing (per treatment course) is weight-based:

• Patients ≥50 kg: 750 mg IV (15 mL) twice, given on two occasions at least 7 days apart (total 1500 mg iron per course) As an alternative, a single 15 mg/kg dose (up to 1000 mg) may be given for adults ≥50 kg.

• Patients <50 kg: 15 mg/kg IV (maximum 750 mg) on two occasions at least 7 days apart (total ≤1500 mg iron per course).

• Maximum single dose: 750 mg of iron (i.e. one vial).

• Maximum per course: 1500 mg of iron (over the two doses).

For administration, the 750 mg dose may be diluted (e.g. in ≤250 mL normal saline) and infused over ≥15 minutes. It can also be given by slow IV push (≈100 mg/min) if undiluted. Patients must be monitored during and for at least 30 minutes after each infusion for signs of hypersensitivity, with resuscitation equipment available. If iron deficiency anemia recurs, a repeat course may be given under the same guidelines.

Adverse Reactions and Precautions

Hypersensitivity: Serious allergic reactions (including anaphylaxis) can occur. Monitor patients for ≥30 minutes after infusion and ensure emergency treatment (e.g. epinephrine) is available. Contraindicated in anyone with a history of hypersensitivity to Injectafer or its components.

Common side effects: In adults (>2%), most often nausea, transient hypertension, flushing, injection-site reactions (pain, erythema), hypophosphatemia, and dizziness. In pediatric patients, common effects include hypophosphatemia, injection-site reactions, rash, headache, and vomiting.

Hypophosphatemia: IV iron can lower serum phosphate. Repeat courses of Injectafer frequently cause transient hypophosphatemia; monitor phosphate in patients at risk. Blood pressure: Transient hypertension can occur; monitor blood pressure during/after infusion

Other considerations: Not for anemia of other causes (oxygenation or B12 deficiency, etc.). Avoid overdose, as iron overload (hemosiderosis) can result. Caution in patients with active infection (bacteria thrive on iron). Patients should be advised to report any symptoms of allergy (rash, itching, dizziness, breathing difficulty, swelling) immediately.

Mechanism of Action

Ferric carboxymaltose is a stable iron complex; after IV administration, iron is slowly released and taken up by macrophages in the reticuloendothelial system. The iron is then incorporated into ferritin and hemoglobin. The stability of the carboxymaltose shell minimizes free iron release and reduces oxidative stress compared to older iron dextrans.

How Injectafer Is Given

Injectafer is administered under the supervision of a healthcare provider, usually at an infusion center, clinic, or hospital setting. It comes in vials as a dark brown, sterile solution containing iron at a concentration of 50 mg per mL. The dosing is often described in terms of elemental iron. A typical course for an adult is a total of 1500 mg of iron, given in two separate doses of 750 mg at least 7 days apart. In practical terms, this might mean an IV infusion (or IV push) of one 750 mg dose, then about a week later the second 750 mg dose, to cumulatively replace 1500 mg of iron. This two-dose regimen is one of Injectafer’s distinguishing features – it allows a large amount of iron to be given over just 1 or 2 sessions, whereas some older IV iron products required 5-10 smaller infusions to get a similar total dose.

For patients with lower body weight (under 50 kg, about 110 lbs), or in pediatric cases, the dose is adjusted to 15 mg per kg body weight, also split into two sessions a week apart. There’s also an option for a single 1000 mg dose for certain adult patients (15 mg/kg up to 1000 mg in one go) if the doctor deems it appropriate), but most often the two-dose approach is used to maximize total iron delivered (since 1500 mg total can be given that way).

The medication can be given as a slow IV push or more commonly diluted into a saline bag and given as an IV drip (infusion) over a period (usually around 15 minutes or so, depending on the dose and facility protocol). This controlled administration allows monitoring during the infusion for any reactions. Injectafer is a dark, amber-colored solution when prepared, and it may temporarily tint the IV tubing or the patient’s urine a darker color – that’s normal due to the iron content. Because it’s given IV, 100% of the iron goes directly into the bloodstream, bypassing the absorption limitations of the gut. This means it can quickly raise iron levels in the body – a big advantage when oral iron isn’t enough.

One important point: Injectafer (and IV irons in general) are not blood transfusions and do not provide red blood cells directly. Instead, they provide the raw material (iron) needed for your body to make its own red blood cells over days and weeks. Patients shouldn’t expect an instantaneous hemoglobin jump the next day; rather, over 2-4 weeks after the infusion, the bone marrow uses that iron to produce more red cells, and hemoglobin typically rises. Many patients, however, report improvement in symptoms (like fatigue or restless legs) within days to a week as iron stores replenish even before the hemoglobin fully recovers.

Benefits of IV Iron (Injectafer) vs Oral Iron

Oral iron supplements (pills or liquid taken by mouth) are often the first-line treatment for mild to moderate iron deficiency. However, oral iron has limits: the body can only absorb a small fraction (often <10% of the iron from oral doses) and many patients experience gastrointestinal side effects (constipation, nausea, black stools). It can take months of daily oral iron to replete iron stores, and some people simply can’t stick with it or don’t absorb it well due to gastric issues or ongoing blood loss.

Injectafer, as an IV iron, ensures 100% absorption because the iron is delivered directly into circulation. It also allows much larger doses of iron in a short time: for example, 1500 mg over a week or two, which would be impossible to achieve with oral iron in that timeframe. For someone who is significantly anemic (say hemoglobin far below normal) or symptomatic, this can make a noticeable difference in how quickly they recover. Injectafer has been shown in clinical trials to effectively raise hemoglobin and iron stores with just those one or two infusions for most patients, whereas oral iron might require daily therapy for 3-6 months. Additionally, because the iron is bound in a carboxymaltose sugar complex, it’s released in a controlled fashion from the bloodstream to iron-binding proteins, making it generally well-tolerated.

Another scenario is patients who simply cannot take oral iron due to intolerance (severe GI upset) or malabsorption (e.g., prior gastric bypass surgery which impairs iron absorption, or inflammatory bowel disease where oral iron worsens gut inflammation). For them, IV iron like Injectafer isn’t just faster – it may be the only effective option to correct the anemia.

Injectafer Side Effects

As with any IV iron product, there are some important safety considerations with Injectafer:

• Allergic Reactions: Although rare, intravenous iron can cause serious hypersensitivity reactions (including anaphylaxis in very rare cases). Patients are usually monitored during the infusion and for at least 30 minutes afterwards for any signs of allergy. Signs of a reaction can include hives, difficulty breathing, dizziness or feeling faint, swelling of the face or throat, or chest tightness. Medical staff will have emergency medications on hand (like epinephrine) just in case. It’s worth noting that older IV irons (like iron dextran) had higher allergic risk; ferric carboxymaltose (Injectafer) has a lower risk, but vigilance is still standard. If you have a known allergy to Injectafer specifically or any of its components, of course it should not be used.

• High Blood Pressure: Some people experience a temporary spike in blood pressure during or after the infusion. This might manifest as a headache, flushing (warmth and redness), dizziness, or a feeling of pounding in the ears. These usually resolve on their own, but healthcare providers will monitor blood pressure during and post-infusion. If someone already has labile hypertension, they’ll be watched closely.

• Low Phosphate Levels (Hypophosphatemia): A known side effect of Injectafer (ferric carboxymaltose) is that it can cause phosphate levels in the blood to drop in some patients. For most people this is mild and without symptoms, but in some cases (especially after repeated doses) it could lead to muscle weakness, fatigue, or bone pain if phosphate becomes very low. In rare instances, it has led to osteomalacia (softening of bones) when untreated. Doctors may check blood phosphate if you’re getting multiple courses of Injectafer or have risk factors for low phosphate. Ensuring a balanced diet or supplements might be advised if levels drop.

• Injection/Infusion Reactions: Aside from allergy, patients can have minor infusion-related effects like nausea or dizziness (these are among the most common side effects, each occurring in a few percent of patients). Headache or flushing are also reported commonly. Some people might feel a bit lightheaded or tired after the infusion, so you may be asked to stay hydrated and possibly remain at the clinic for a short observation period. There can also be local reactions such as pain, bruising, or discoloration at the IV site if any of the iron leaks outside the vein (known as extravasation). The staff take care to inject it properly, but if you feel burning or severe pain at the IV site, alert them – they’ll check to ensure the IV is still in the vein well.

• Iron Overload: Injectafer should not be given to people with iron overload conditions (like hemochromatosis) or anemia that isn’t due to iron deficiency (for example, anemia of chronic disease without iron deficiency). Before starting therapy, typically the doctor will do blood tests (iron levels, transferrin saturation, ferritin) to confirm that you are truly iron-deficient. Getting too much iron can deposit in organs and cause damage, so the treatment is carefully matched to the degree of deficiency. That said, the dosing schedules are designed so that for most patients, one course restores iron to normal – if more is needed, they will check levels and not just give endless iron without monitoring. Signs of having too much iron (iron overload) after treatment could include joint pain, fatigue, heart rhythm changes or liver issues, but these are unlikely if the medication is used appropriately.

• Other Side Effects: In clinical trials, other side effects that occurred in some patients include rash, itching, or mild transient changes in lab tests (like liver enzymes). Many people actually feel significantly better a week or two after Injectafer as their anemia improves, despite maybe having a day or two of minor side effects right after the infusion (like headache or nausea). If you’ve had any reaction to other IV irons in the past, let your doctor know, as that might influence the choice of product or premedication.

Practical Points and What to Expect

• Prior to Infusion: Your healthcare provider will likely do blood tests to confirm you need IV iron and to establish baselines (hemoglobin, ferritin, iron saturation, etc). On the day of infusion, you might be advised to eat a light meal and be well-hydrated. Unlike some infusions, no special premedication is routinely required for Injectafer (unless you have a history of infusion reactions, in which case they might give an antihistamine or steroid beforehand as a precaution).

• During Infusion: Injectafer is typically given in a controlled setting. If it’s given by IV drip, you’ll sit in a chair while a diluted solution of Injectafer flows into your vein over ~15 minutes (the infusion time can vary). If given by IV push (undiluted), it’s injected slowly over ~8 minutes for the 750 mg dose, but many centers prefer the drip method for patient comfort. You shouldn’t feel much aside from maybe a cool sensation in the arm. Nurses will monitor your blood pressure and ask how you’re feeling. If you notice any rash, chest tightness, or difficulty breathing, report it immediately. Most people tolerate it without serious issues.

• After Infusion: You’ll often be observed for about 30 minutes once the dose is complete. Assuming all is well, you can then go home. It’s a good idea to have someone drive you if possible, especially for your first infusion, in case you feel dizzy or have a headache. However, many people are fine to drive themselves afterwards. Make sure to continue any oral iron only if your doctor advises – often, they’ll have you pause oral iron around the time of IV iron to avoid any confusing symptoms or overload. Do not take extra iron supplements on your own after Injectafer unless instructed, since Injectafer is usually sufficient and adding more iron pills could cause high iron or side effects like constipation.

• Effectiveness: Over the next weeks, your doctor will recheck your blood counts. Typically, a rise in hemoglobin is seen within 2-4 weeks. Patients often report improved energy, less shortness of breath on exertion, and better concentration as the anemia resolves. If you have chronic conditions causing ongoing iron loss, the doctor might schedule repeat courses of Injectafer down the line (Injectafer treatment can be repeated if iron deficiency returns. Some patients with chronic kidney disease, for instance, might get IV iron a few times a year to maintain levels.

• Cost and Logistics: Injectafer can be expensive, but many insurance plans cover it, especially if it’s medically justified that oral iron isn’t working. It’s given in a medical setting, so there may be co-pays for an outpatient infusion visit. There are assistance programs for those who qualify, as noted on the official Injectafer website. It’s not something you’d pick up at a retail pharmacy – it’s usually ordered by the clinic and given to you on-site.